Galectin Therapeutics (GALT) Interest Coverage Ratio Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 40.09% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 54.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.98% |
| Dec 31, 2025 | 63.09% |
| Sep 30, 2025 | 57.57% |
| Jun 30, 2025 | 60.84% |
| Mar 31, 2025 | 53.05% |
| Dec 31, 2024 | 35.86% |
| Sep 30, 2024 | 82.73% |
| Jun 30, 2024 | 54.81% |
| Mar 31, 2024 | 68.27% |
| Dec 31, 2023 | 68.35% |
| Sep 30, 2023 | 65.59% |
| Jun 30, 2023 | 63.74% |
| Mar 31, 2023 | 48.32% |
| Dec 31, 2022 | 47.30% |
| Sep 30, 2022 | 38.55% |
| Jun 30, 2022 | 33.55% |
| Mar 31, 2022 | 25.91% |
| Dec 31, 2021 | 9.89% |
| Sep 30, 2021 | -236.88% |
| Jun 30, 2021 | -29.66% |
| Mar 31, 2021 | -79.39% |